TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bonia Corporation Bhd
KLSE:BONIA
|
MY |
|
O
|
OneForce Holdings Ltd
HKEX:1933
|
HK |
|
L
|
Legacy Iron Ore Ltd
ASX:LCY
|
AU |
|
S
|
Sandstorm Gold Ltd
NYSE:SAND
|
CA |
|
M
|
MMAG Holdings Bhd
KLSE:MMAG
|
MY |
|
M
|
MK Exim (India) Ltd
BSE:538890
|
IN |
|
Steelcase Inc
NYSE:SCS
|
US |
|
R
|
Red Metal Resources Ltd
CNSX:RMES
|
CA |
|
Hexpol AB
STO:HPOL B
|
SE |
|
F
|
Friend Co Ltd
SSE:605050
|
CN |
|
M
|
Mars Group Holdings Corp
TSE:6419
|
JP |
|
B
|
Bright Packaging Industry Berhad
KLSE:MBRIGHT
|
MY |
|
E
|
EN Shoham Business Ltd
TASE:SHOM
|
IL |
|
H
|
Hwa Create Corp
SZSE:300045
|
CN |
|
O
|
Odlewnie Polskie SA
WSE:ODL
|
PL |
|
Solar A/S
CSE:SOLAR B
|
DK |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Sanne Group PLC
LSE:SNN
|
JE |
|
La Opala R G Ltd
NSE:LAOPALA
|
IN |
|
S
|
Shandong Ruifeng Chemical Co Ltd
SZSE:300243
|
CN |
|
N
|
New Horizon Aircraft Ltd
NASDAQ:HOVR
|
CA |
|
Z
|
Zhongnongfa Seed Industry Group Co Ltd
SSE:600313
|
CN |
|
Marumae Co Ltd
TSE:6264
|
JP |
|
Mirada PLC
LSE:MIRA
|
UK |
TiumBio Co Ltd
Total Equity
TiumBio Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
Total Equity
₩52.5B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Total Equity
₩17.2T
|
CAGR 3-Years
61%
|
CAGR 5-Years
39%
|
CAGR 10-Years
27%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Total Equity
₩149.4B
|
CAGR 3-Years
31%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Equity
₩66.4B
|
CAGR 3-Years
113%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Equity
₩445.2B
|
CAGR 3-Years
44%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Equity
₩154.7B
|
CAGR 3-Years
31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
TiumBio Co Ltd
Glance View
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
See Also
What is TiumBio Co Ltd's Total Equity?
Total Equity
52.5B
KRW
Based on the financial report for Dec 31, 2024, TiumBio Co Ltd's Total Equity amounts to 52.5B KRW.
What is TiumBio Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
-11%
Over the last year, the Total Equity growth was -25%. The average annual Total Equity growth rates for TiumBio Co Ltd have been -16% over the past three years , -11% over the past five years .
